Evidence map›Paper›PMID 40247020›Full record

ArticleNature materials2025

Bioinstructive scaffolds enhance stem cell engraftment for functional tissue regeneration.

Di Wu, Ioannis Eugenis, Caroline Hu, Soochi Kim, Abhijnya Kanugovi, Shouzheng Yue, Joshua R Wheeler, Iman Fathali, Sonali Feeley, Joseph B Shrager and 2 more

Abstract read
In one paragraph

Article in Nature materials, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. In Vivo T-Cell Engineering: Revolution in Delivery Strategies and Clinical Translation.BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy · 2026
    Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Di WuDepartment of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, USA.ORCID 0000-0002-3238-6388
Ioannis EugenisDepartment of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, USA.
Caroline HuVeterans Affairs Palo Alto Health Care System, Palo Alto, CA, USA.
Soochi KimDepartment of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, USA.
Abhijnya KanugoviDepartment of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, USA.
Shouzheng YueDepartment of Neurology, UCLA, Los Angeles, CA, USA.ORCID 0000-0002-8485-5959
Joshua R WheelerDepartment of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
Iman FathaliDepartment of Cardiothoracic Surgery, Stanford University, Stanford, CA, USA.ORCID 0009-0003-7388-7829
Sonali FeeleyDepartment of Neurology, UCLA, Los Angeles, CA, USA.
Joseph B ShragerVeterans Affairs Palo Alto Health Care System, Palo Alto, CA, USA.
Ngan F HuangVeterans Affairs Palo Alto Health Care System, Palo Alto, CA, USA.ORCID 0000-0003-2298-6790
Thomas A RandoDepartment of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, USA. trando@mednet.ucla.edu.ORCID 0000-0001-5843-8564

Funding

Wnt signaling in muscle stem cell agingP01AG036695 · NIA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MARGARET A. GOODELL · 2011 to 2026
$29.3M
Aging and Stem Cell ResilienceR01AG068667 · NIA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI RANDO, THOMAS A. · 2021 to 2025
$2.8M
Development of a Bioengineered Therapeutic Device for the Prevention of LymphedemaR01CA285372 · NCI · PALO ALTO VETERANS INSTIT FOR RESEARCH · PI Ngan F. Huang, Michael Vitoldovich Paukshto · 2024 to 2026
$1.6M
Biomaterials for delivery and maintenance of tip endothelial cellsR21HL172096 · NHLBI · UNIVERSITY OF CALIFORNIA, MERCED · PI HUANG, NGAN F., MCCLOSKEY, KARA E · 2024 to 2025
$643k
Novel Highly Regenerative and Scalable Progenitor Cell Exosomes for Treating Peripheral Artery DiseaseR41HL170875 · NHLBI · SERINA THERAPEUTICS, INC. · PI HUANG, NGAN F., LEE, JI EUN · 2023 to 2023
$341k
BLRD VA I01 BX004259BLRD VA IK6 BX006309NCI NIH HHS R01 CA285372NHLBI NIH HHS R21 HL172096NHLBI NIH HHS R41 HL170875NIA NIH HHS P01 AG036695NIA NIH HHS R01 AG068667RRD VA I01 RX001222RRD VA I21 RX004898
6 · The paper itself

Abstract

Stem cell therapy is a promising approach for tissue regeneration after traumatic injury, yet current applications are limited by inadequate control over the fate of stem cells after transplantation. Here we introduce a bioconstruct engineered for the staged release of growth factors, tailored to direct different phases of muscle regeneration. The bioconstruct is composed of a decellularized extracellular matrix containing polymeric nanocapsules sequentially releasing basic fibroblast growth factor and insulin-like growth factor 1, which promote the proliferation and differentiation of muscle stem cells, respectively. When applied to a volumetric muscle loss defect in an animal model, the bioconstruct enhances myofibre formation, angiogenesis, innervation and functional restoration. Further, it promotes functional muscle formation with human or aged murine muscle stem cells, highlighting the translational potential of this bioconstruct. Overall, these results highlight the potential of bioconstructs with orchestrated growth factor release for stem cell therapies in traumatic injury.

Indexed as

RegenerationStem CellsStem Cell TransplantationTissue ScaffoldsAnimalsCell DifferentiationCell ProliferationFibroblast Growth Factor 2HumansInsulin-Like Growth Factor IMiceTissue EngineeringFibroblast Growth Factor 2Insulin-Like Growth Factor I

Identifiers

PMID40247020
PMCPMC12777987

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.